A total of 242 early stage breast cancer patients (Stage 0-2) were prospectively enrolled; 107 underwent BCT, 56 MA and 79 IBR. Patient's in the BCT group were older at baseline (60 ± 11 years old) compared to MA (52 ± 12 years) or IBR (49 ± 10 years) (p<0.0001). The majority of IBR cases were bilateral (66%), whereas they comprised only 32% of MA and 5% of BCT (p<0.0001). Education, income, and ethnicity were comparable between groups at baseline. The three groups had similar baseline BS and PSW scores (p=0.17 and p=0.71). At 12 months, BCT had the highest BREAST-Q scores, with 68/100 for BS and 79/100 for PSW (p<0.0001), compared to, respectively, 57 and 65 for IBR, and 48 and 57 for MA. After multivariable regression accounting for patient's age, income, education, ethnicity, cancer stage and laterality, BS BREAST-Q change from baseline to 12 months was not statistically different for BCT and IBR (p=0.0662), while MA patients experienced lower BS compared to BCT (p<0.0001). IBR patients had no different BS when compared to MA (p=0.16). With regards to PSW, similar patterns were present. IBR patients had no different PSW than BCT (p=0.25), while MA patients experienced lower wellbeing compared to BCT (p<0.0001). IBR had higher PSW compared to MA (p=0.0039).
CONCLUSION:
This large prospective study highlights that changes in breast satisfaction and psychosocial wellbeing at 12 months for BCT and IBR are no different in early stage breast cancer patients, but are significantly reduced in MA. This study is the first to compare BREAST-Q outcomes between BCT, MA and IBR, and provides important evidence to support the use of BCT and IBR to optimize long-term quality of life and breast satisfaction for early stage breast cancer patients. 
METHODS:
A retrospective case-control study was conducted over a 6-year period. 544 consecutive DIEP flaps were divided into a control group without previous abdominal surgery, and an incision group with previous abdominal surgery. A comparison between both groups was made in terms of flap and donor site complications, followed a subgroup analysis based on the type of abdominal incision.
RESULTS: 223 flaps were included in the incision group and 321 in the control group. There were no significant differences between groups in terms of age, flap weight, smoking history, prior radiation history and comorbidities. We found a higher BMI in the incision group (p=0.01). There were no significant differences between the control group and the incision group in terms of flap complications (complete flap loss, partial flap loss and fat necrosis). However, donor site complications, specifically wound separation was found to occur at a higher incidence in the incision group (p=0.0001). In the sub-group analysis, patients with a low transverse incision had higher rates of fat necrosis (8.0% vs 23% p=0.0001) and donor site wound separation (9.0% vs 23% p=0.002) . No statistically significant differences were found between patients in the control group and those with laparoscopic incisions on the one hand, and those with a combination of laparoscopic and low transverse incision on the other.
CONCLUSION:
The results from this large series of consecutive DIEP flaps from our institution confirms that autologous breast reconstruction with a DIEP flap can be safety performed in patients who have had previous abdominal surgeries; however, patients must be made aware of the increased risk of donor site complications. 
